Antiretroviral Drugs as the Linchpin for Prevention of HIV Infections in the United States
- PMID: 28902548
- PMCID: PMC5607687
- DOI: 10.2105/AJPH.2017.304011
Antiretroviral Drugs as the Linchpin for Prevention of HIV Infections in the United States
References
-
- Farnham PG, Gopalappa C, Sansom SL et al. Updates of lifetime costs of care and quality-of-life estimates for HIV-infected persons in the United States: late versus early diagnosis and entry into care. J Acquir Immune Defic Syndr. 2013;64(2):183–189. - PubMed
-
- Skarbinski J, Rosenberg E, Paz-Bailey G et al. HIV transmission at each step of the care continuum in the United States. JAMA Intern Med. 2015;175(4):588–596. - PubMed
-
- AVAC: Global Advocacy for HIV Prevention. Evidence for HIV prevention options. 2016. Available at: http://www.avac.org/infographic/evidence-hiv-prevention-options#l. Accessed March 30, 2017.
-
- Centers for Disease Control and Prevention. HIV prevention in the United States: new opportunities, new expectations. 2015. Available at: http://www.cdc.gov/hiv/pdf/policies/cdc-hiv-prevention-bluebook.pdf. Accessed March 3, 2017.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical